SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-020713
Filing Date
2023-06-02
Accepted
2023-06-02 18:17:40
Documents
3
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1685744248.html 4  
1 FORM 4 wk-form4_1685744248.xml 4 3498
2 EX-24 skovronskypoaform2022062.htm EX-24 4364
3 GRAPHIC skovronskypoaform2022062001.jpg GRAPHIC 259674
  Complete submission text file 0001628280-23-020713.txt   366923
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Skovronsky Daniel (Reporting) CIK: 0001741474 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 23990576